Pharma podcast production that plans around your MLR review
Your scientists, medical experts, and policy leads have plenty to say. Your review process decides when they can say it. We build the production schedule around that process, so the calendar stops being the surprise.
We handle recording, editing, and distribution. Your medical, legal, and regulatory teams keep every decision about what gets said and what gets published.
Organizations that already record with us
Each logo below is a group whose show went through our studio.
Two things sink a pharma podcast, and only one is review
The first is the calendar. Teams making finance podcasts know this too. When review gets added after the recording, the release date moves every time. So we ask about your review process on the first call and plan the schedule around it.
The second is quieter. A show can clear review and still lose the listener. Content that sounds like a conference abstract is easy to approve and hard to finish. A conversation built around a person and a real question is easier to follow.
We can plan the calendar, and we will push for a better conversation. We cannot shorten your review, and we would not try.
Your review team decides, and we keep the schedule
Pharma teams tend to ask about this first, so here is the short answer. Regulatory, legal, and compliance calls belong to your organization, and we stay out of them.
What stays with you
- Everything about what each episode says.
- Medical, legal, and regulatory review and sign-off.
- Deciding whether an episode counts as promotional material, and what that requires.
- The last yes before anything goes public.
What we handle
- A release calendar that holds space for each MLR pass.
- Recording, editing, and mastering.
- Routing cuts to the medical and legal names on your list.
- Edits that come back from your reviewers.
- Release to listeners after sign-off.
How do we fit production around MLR review?
No two pharma companies run MLR the same way, so we start from your process. This is the usual order we sort it in.
Map your review path
Early on, we learn which functions sign off, the sequence they follow, and their typical turnaround. Your own timing sets the plan.
Choose the review stops
Your reviewers pick their checkpoints. That might be the interview outline, the finished cut, or the clips and transcript.
Build in slack
Sessions get booked well ahead of release, so a long MLR pass leaves the date intact. Nobody on your side has to hurry.
Publish after sign-off
An episode stays private until approval lands. When reviewers flag a line, we fix it and route it back to them.
What kind of show fits your organization?
Pick the audience first. Then think about what your review process does to each kind of content, and choose a format your team can keep up.
| # | Format | What it covers and why it fits |
|---|---|---|
| 01 | Policy and market access shows | Interviews on drug pricing, pharmacy benefit managers, and affordability policy, close kin to some law firm shows. It is the format behind Prescription for Better Access, and it puts your voice inside the access conversation. |
| 02 | Scientific storytelling | Your researchers and R&D leads explain the science behind a therapeutic area. It can build standing with clinicians and investigators. A story carries it better than a lecture. |
| 03 | Medical affairs and industry commentary | A recurring show on industry trends, policy shifts, and the competition. Medical affairs and business development audiences follow these topics closely. |
| 04 | Internal and R&D communications | Private shows for scientific teams and for updates across sites and functions. Only the staff you add can subscribe and listen, through private podcast hosting. |
Build the package that fits your organization
Use every service or just the parts you need. One crew handles all of it, and MLR timing is set before the first session.
Pricing for the full-service plan sits between $2,100 and $6,500 a month. Use the pricing estimator for a quick ballpark.
Make the show
- Podcast launch: strategy through your first episode live, with your internal review timeline built in from day one.
- Audio production: MLR-bound episodes get a degree-trained engineer for edit, mix, and master, with cuts ready in 3 to 5 business days.
- Video production: YouTube-ready video and short clips that follow the audio through MLR.
- Podcast management: your producer works around submission deadlines and the medical affairs calendar.
Get it heard
- Podcast marketing: transcripts, video clips, and audiograms (short audio snippets set to motion graphics), each ready for review before release.
- Transcripts give readers and search engines words to work with.
- Public hosting: an open show reaches listeners on Apple, Spotify, and YouTube.
- A private feed stays inside the company, a good fit for R&D and medical affairs briefings.
Prescription for Better Access
Mark Hansan and Dr. Scott Howell co-host this interview show about patient access and affordability. It covers high-cost specialty drugs, drug pricing policy, and the barriers between patients and treatment. We have produced it since 2023.
Common questions about pharma and biotech podcast production
Everything worth knowing before you start or restart a show for your organization.
What is a pharma or biotech podcast?
It is a podcast that a drug maker, biotech firm, or market access group produces or sponsors. Goals vary. Some shows build scientific credibility, some take a position on policy and access, and some reach healthcare professionals. Each one runs inside whatever review requirements your organization already has.
Why do most pharma podcasts fail?
Nobody publishes a failure rate, so we cannot give you a number. We can tell you the two causes we plan for. One is a calendar that collides with review. The other is content that is accurate but hard to finish. A show built around a real person and a real question gives listeners a reason to stay.
How does MLR review affect a pharma podcast schedule?
MLR stands for medical, legal, and regulatory review. Turnaround swings widely between companies and content types, so averages do little good. We ask what yours really is and put it into the managed production calendar from day one. Your MLR function decides what needs review and what clears. We schedule around it and never try to shorten it.
What does a pharma podcast production agency do?
It handles strategy, recording, editing, video, and distribution. For a pharma client it also builds the schedule around the internal review process. Similar planning applies on our healthcare podcasts.
Who handles regulatory compliance for a pharma podcast?
Your organization does. We run recording and editing and keep the calendar loose enough for MLR. Your medical, legal, and regulatory teams keep responsibility for regulatory standards and promotional compliance. FDA's Office of Prescription Drug Promotion oversees prescription drug advertising and promotional labeling. Whether an episode falls under those rules is a decision for your team.
What kind of podcast should a pharma or biotech company launch?
Three formats come up most often. A policy and market access show covers drug pricing and affordability. A scientific storytelling show puts your researchers and R&D leads on air. An industry commentary show serves medical affairs and business development audiences. Pick based on your audience and how heavy MLR gets for that topic. A launch plan helps you test the fit early.
How much does pharma podcast production cost?
Full-service plans cost $2,100 to $6,500 a month. Cadence, video needs, and how many reviewers touch each episode decide where you fall. Private hosting for internal shows starts at $1,000 a month. Slow MLR cycles need more early planning, and scope reflects that. Compare in-house versus agency costs, then talk to us for a real quote.
What makes a pharma podcast different from other branded shows?
Your listeners are clinicians, policy stakeholders, and industry peers instead of consumers. Your episodes also pass through a review step that most branded shows never face. Both facts shape your format, your topics, and your calendar from the first planning call. See how our process works for the general version.
Has Resonate produced podcasts for pharma or biotech organizations specifically?
Yes. We produce Prescription for Better Access, co-hosted by Mark Hansan and Dr. Scott Howell. It covers patient access and drug pricing policy, and it has run since 2023. You can listen to it above, or browse more client shows.
Looking for your industry?
Pharma is one of several regulated fields we work in. Wherever sign-off is strict, your reviewers set the pace and keep the legal calls, and we plan around them.
Let's plan a show your review team can say yes to
Thirty minutes. We talk through your audience, your review process, and what a production schedule looks like for your organization.